Sunrest Lifescience Limited (NSE:SUNREST)

India · Delayed Price · Currency is INR

38.50

+3.00 (8.45%)

Oct 6, 2026, 12:37 PM IST

Market Cap	165.21M -18.4%
Revenue (ttm)	708.33M +112.0%
Net Income	41.16M +105.3%
EPS	9.59 +105.4%
Shares Out	4.29M
PE Ratio	4.01
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	3,200
Open	38.50
Previous Close	35.50
Day's Range	38.50 - 38.50
52-Week Range	29.55 - 54.00
Beta	0.16
Analysts	n/a
Price Target	n/a
Est. Earnings	Nov 13, 2026

About Sunrest Lifescience

Sunrest Lifescience Limited manufactures, sells, and markets healthcare products, medicines, and cosmetic products in India. It markets various drugs, including anti-bacterials, anti-spasmodic and enzyme, antibiotics, anti-amoeibics, anti- fungals, anti-diabetic, analgesic, antihelmintics, antacid anti emetics, neuropathy, anti-pyretic, anti-hypertension, anti-inflammatory, anti-ulcerants, anti-cold, anti-cough, anti-allergics, nutritionals, ayurvedic; lady, oral, skin, and hair care products; multi vitamins and haemantinics; and cosmetics in v... [Read more]

Industry Medical - Pharmaceuticals

Sector Healthcare

Founded 2017

Employees 210

Stock Exchange National Stock Exchange of India

Ticker Symbol SUNREST

Full Company Profile

Financial Performance

In fiscal year 2026, Sunrest Lifescience's revenue was 708.33 million, an increase of 111.99% compared to the previous year's 334.13 million. Earnings were 41.16 million, an increase of 105.27%.

Financial Statements